Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pig Vet Society reviews highest priority antibiotics
The Pig Veterinary Society (PVS) is to adopt the European Medicines Agency’s (EMA’s) list of highest-priority Critically Important Antibiotics. 

Organisation adopts list of ‘critical’ antibiotics

The Pig Veterinary Society (PVS) is to adopt the European Medicines Agency’s (EMA’s) list of highest-priority Critically Important Antibiotics (CIAs).

The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and Colistin will retain class three status.

This means they will only be used when no other options are available and when supported by laboratory sensitivity testing - or when all other options have failed.

The PVS states that its decision follows a review by its Medicines Sub-Committee, and coincides with a move last month from RUMA to align with the EMA position.

Mark White, PVS president commented: “The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
 
“This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70 per cent in 2016 following its move to a Class 3 antibiotic in late 2015.
 
“We must also continue to be alert to the possibility of cross-resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative.”

In a statement, the PVS writes that antibiotics in Class 1 make up the standard prescribing list within responsible use guidelines. Class 2 should only be used when sensitivity tests or clinical experience proves standard antibiotics are not effective.

'In all treatment decisions, the health and welfare of the pigs must always take priority,' it adds.

The PVS has also reviewed the risk of beta-lactams with beta-lactamase inhibitors and has reclassified them from Class 3 to Class 2. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.

Welcoming the review, RUMA secretary general John FitzGerald said: “Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.